To study the efficacy of pain relieving medication ketamine on post operative pain in patients with ultrasound guided neck block undergoing keyhole shoulder surgery.

Efficacy of intravenous ketamine vs normal saline as an adjunct to ropivacaine and fentanyl combination in ultrasound guided continuous interscalene block for arthroscopic shoulder surgery.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/018898

Enrollment

Registered

2019-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S430- Subluxation and dislocation of shoulder joint

Interventions

Intervention1: Intravenous ketamine: patients will receive intravenous ketamine peri-operatively(bolus of intravenous ketamine before incision and infusion of ketamine is given intraoperatively, stopp

Eligibility

Inclusion criteria

Inclusion criteria: 1.American society of anesthesiologist(ASA) physical status 1-2. 2.Age 18-65 years. 3.BMI-18-30kg/m2 of either sex. 4.Arthroscopic shoulder surgery, especially rotator cuff injury repair and recurrent shoulder dislocations.

Exclusion criteria

Exclusion criteria: 1 Patients refusing to give informed consent 2 History of relevant drug allergy 3 History of psychiatric illness, substance abuse 4 severe cardiovascular, respiratory, metabolic, or neurological disease 5 Pregnancy and lactation 6 Coagulopathy 7 Contralateral phrenic nerve dysfunction 8 Infection at planned injection site 9 Patients receiving alpha 2 agonists for hypertensive disorders 10 Patients on steroids

Design outcomes

Primary

Measure	Time frame
Time for first bolus administration- as a marker for duration of analgesiaTimepoint: Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs.	—

Secondary

Measure	Time frame
1.Measures pain ratings over 48 hrs on 0-100 VAS. 2.Total postoperative analgesic consumption 3.Patient satisfaction 4.Adverse effects.Timepoint: 1.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs. 2.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs. 3.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs. 4.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs.	—

Measure

Time frame

1.Measures pain ratings over 48 hrs on 0-100 VAS. 2.Total postoperative analgesic consumption 3.Patient satisfaction 4.Adverse effects.Timepoint: 1.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs. 2.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs. 3.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs. 4.Postoperative at 4,6,8,10,12,14,16,18,20,22,24,30,36,42,48 hrs.

—

Countries

India

Contacts

Public ContactDr Sukanya Mitra

Government Medical College and Hospital s

drsmitra12@yahoo.com9646121521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026